ProSomnus Sleep Technologies is dedicated to helping dentists treat the growing number of patients with Obstructive Sleep Apnea
San Francisco, CA, September 26, 2016 – ProSomnus Sleep Technologies, manufacturer of the award-winning MicrO2® Sleep and Snore Device, announces the appointment of Dr. Mark T. Murphy as Lead Faculty and Mr. Jerry Vogel as Vice President of Sales. Dr. Murphy and Mr. Vogel join Len Liptak, Bob Starr, Sung Kim and Dave Kuhns on the ProSomnus Executive Team.
“ProSomnus is on a mission to help dentists address the most important challenges in Oral Appliance Therapy for the treatment of Obstructive Sleep Apnea, including patient compliance, reducing the untreated population, and improving practice efficiency,” stated Len Liptak, CEO of ProSomnus Sleep Technologies. “Mark and Jerry are central to these ambitious and important plans. Both offer a rare proficiency in collaborating with dentists to develop innovative and impactful products, processes and programs.”
Dr. Mark T. Murphy has lectured internationally on Leadership, Practice Management, Communication, Case Acceptance, Planning, Occlusion, TMD and Obstructive Sleep Apnea. Mark has been involved in Sleep Dentistry for over 25 years. He is an active member of the American Academy of Dental Sleep Medicine, and has trained with several of the leading sleep dentists and post-graduate training institutes.
Jerry Vogel brings a wealth of sales and executive management experience to ProSomnus. Prior to joining ProSomnus, Jerry successfully commercialized numerous dental sleep medicine and dental implant restorative and prosthetic implant products for Panthera and Nobel Biocare. Mr. Vogel’s experience also includes the development and implementation of sleep and implant therapies as practice development initiatives.
About ProSomnus Sleep Technologies
ProSomnus Sleep Technologies designs, manufactures and markets innovative intraoral sleep devices that dentists use to treat patients diagnosed with Obstructive Sleep Apnea. The company’s flagship product is the MicrO2® Sleep Device. The MicrO2 Sleep Device is a FDA Cleared Class II Medical Device that is smaller, stronger, more biocompatible, and more precise than predicate intraoral sleep apnea devices, allowing dentists to get patients into therapy faster, and with greater comfort and simplicity. The MicrO2 has been used to treat thousands of patients, with clinical performance that has been validated in controlled trials, retrospective cohort studies, and numerous clinical case reports.